ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SPI Spire Healthcare Group Plc

176.60
-3.40 (-1.89%)
20 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.40 -1.89% 176.60 176.20 176.60 182.20 176.20 181.40 2,044,907 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Health & Allied Services,nec 1.51B 25.4M 0.0631 27.92 724.95M

Spire Healthcare Group PLC Form 8 (OPD) (Mediclinic International plc) (6626V)

06/11/2017 11:55am

UK Regulatory


Spire Healthcare (LSE:SPI)
Historical Stock Chart


From Mar 2020 to Mar 2025

Click Here for more Spire Healthcare Charts.

TIDMSPI TIDMMDC

RNS Number : 6626V

Spire Healthcare Group PLC

06 November 2017

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                 SPIRE HEALTHCARE GROUP PLC 
----------------------------------------------------------  ---------------------------------------------------------- 
 (b) Owner or controller of interests and short positions    N/A 
 disclosed, if different from 1(a): 
 The naming of nominee or vehicle companies is 
 insufficient. For a trust, the trustee(s), 
 settlor and beneficiaries must be named. 
----------------------------------------------------------  ---------------------------------------------------------- 
 (c) Name of offeror/offeree in relation to whose relevant   MEDICLINIC INTERNATIONAL PLC (OFFEROR) 
 securities this form relates: 
 Use a separate form for each offeror/offeree 
----------------------------------------------------------  ---------------------------------------------------------- 
 (d) Is the discloser the offeror or the offeree?            OFFEREE 
----------------------------------------------------------  ---------------------------------------------------------- 
 (e) Date position held:                                     3 NOVEMBER 2017 
  The latest practicable date prior to the disclosure 
----------------------------------------------------------  ---------------------------------------------------------- 
 (f) In addition to the company in 1(c) above, is the        YES, IN RESPECT OF SPIRE HEALTHCARE GROUP PLC (AS 
 discloser making disclosures in respect                     OFFEREE) 
 of any other party to the offer? 
 If it is a cash offer or possible cash offer, state "N/A" 
----------------------------------------------------------  ---------------------------------------------------------- 
 
   2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 
 Class of relevant security:                                                           Ordinary Shares of 1 pence 
-------------------------------------------------------------------------------  ------------------------------------- 
                                                                                     Interests        Short positions 
-------------------------------------------------------------------------------  -----------------  ------------------ 
                                                                                    Number      %       Number       % 
-------------------------------------------------------------------------------  ------------  ---  -------------- 
 (1) Relevant securities owned and/or controlled:                                     Nil       -         Nil        - 
-------------------------------------------------------------------------------  ------------  ---  -------------- 
 (2) Cash-settled derivatives:                                                        Nil       -         Nil        - 
-------------------------------------------------------------------------------  ------------  ---  -------------- 
 (3) Stock-settled derivatives (including options) and agreements to                  Nil       -         Nil        - 
 purchase/sell: 
-------------------------------------------------------------------------------  ------------  ---  -------------- 
 TOTAL:                                                                               Nil       -         Nil        - 
-------------------------------------------------------------------------------  ------------  ---  -------------- 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities 
 
 Class of relevant security in relation to which subscription right exists:    NONE 
----------------------------------------------------------------------------  ----- 
 Details, including nature of the rights concerned and relevant percentages:   NONE 
----------------------------------------------------------------------------  ----- 
 
   3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE 
 
 Details of any interests, short positions and rights to subscribe (including directors' and 
  other employee options) of any person acting in concert with the party to the offer making 
  the disclosure: 
---------------------------------------------------------------------------------------------------- 
 3(a) Interests of directors of Spire Healthcare Group plc and their connected persons in Mediclinic 
  International Plc ordinary shares 
   Director               Beneficial            Number         Percentage 
                           or non-beneficial     of ordinary    of total issued 
                                                 shares         share capital 
                                                                (excluding 
                                                                treasury shares) 
                                                                (%) 
  ---------------------  --------------------  -------------  ------------------ 
 
   Danie Meintjes         Beneficial            173,323        0.02% 
  ---------------------  --------------------  -------------  ------------------ 
   Lydia Meintjes 
    (major daughter 
    of Danie Meintjes)    Non-beneficial        672            0.00% 
  ---------------------  --------------------  -------------  ------------------ 
 
 
  3(b) Interests held by Spire Healthcare Group plc directors in awards of ordinary shares under 
  Mediclinic International plc share plans 
 
  Mediclinic International plc Forfeitable Share Plan 
   Director         Award Date   Date Accepted   Number       Vesting 
                                                  of shares    Date 
  ---------------  -----------  --------------  -----------  -------- 
 
   Danie Meintjes   23 June      17 June         43,524       31 May 
                     2015         2015                         2018 
  ---------------  -----------  --------------  -----------  -------- 
 
 
  Mediclinic International plc Long Term Incentive Plan 2013 
   Director    Award Date    Number of   Vesting Date 
                              shares 
  ----------  ------------  ----------  ------------- 
   Danie Meintjes 
  --------------------------------------------------- 
               14 June       101,376     14 June 2021 
                2016 
  ----------  ------------  ----------  ------------- 
               01 June       129,626     31 May 2020 
                2017 
  ----------  ------------  ----------  ------------- 
   Total                     231,002 
  ------------------------  ----------  ------------- 
 
 
 
  Mediclinic International plc Short Term Incentive Plan 2015 
   Director    Award Date    Number of   Vesting Date 
                              shares 
  ----------  ------------  ----------  ------------- 
   Danie Meintjes 
  --------------------------------------------------- 
               01 June       27,187      31 May 2019 
                2017 
  ----------  ------------  ----------  ------------- 
   Total                     27,187 
  ------------------------  ----------  ------------- 
 
 
  3(c) Interests of connected advisors 
 
  Goldman Sachs International 
                         Interests       Short Positions 
  --------------------  --------------  ------------------ 
                         Number   %      Number      % 
  --------------------  -------  -----  ----------  ------ 
   (1) Relevant 
    securities 
    owned and/or 
    controlled:            0      0.00     6,092     0.00 
  --------------------  -------  -----  ----------  ------ 
   (2) Cash-settled 
    derivatives:         68,089   0.00    85,850     0.01 
  --------------------  -------  -----  ----------  ------ 
   (3) Stock-settled 
    derivatives 
    (including 
    options) 
    and agreement 
    to purchase/sell:      0      0.00       0       0.00 
  --------------------  -------  -----  ----------  ------ 
   Total                 68,089   0.00    91,942     0.01 
  --------------------  -------  -----  ----------  ------ 
---------------------------------------------------------------------------------------------------- 
 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer making the disclosure or any person acting 
  in concert with it: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
------------------------------------------------------------------------------------------------ 
 
   NONE 
------------------------------------------------------------------------------------------------ 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer making the disclosure, or any person acting in concert with it, and any other 
  person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
---------------------------------------------------------------------------------------------- 
 
   NONE 
---------------------------------------------------------------------------------------------- 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
-------------------------------------  --- 
 Supplemental Form 8 (SBL)              NO 
-------------------------------------  --- 
 
 
 Date of disclosure:    6 November 2017 
---------------------  ---------------- 
 Contact name:          Daniel Toner 
---------------------  ---------------- 
 Telephone number:      02074 279080 
---------------------  ---------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

FEEFSFFFMFWSEIF

(END) Dow Jones Newswires

November 06, 2017 06:55 ET (11:55 GMT)

1 Year Spire Healthcare Chart

1 Year Spire Healthcare Chart

1 Month Spire Healthcare Chart

1 Month Spire Healthcare Chart